Lenalidomide and Rituximab as Treatment of Chronic Lymphocytic Leukemia

Clinical trial NCT00759603 · COMPLETED

Trial details

NCT number: NCT00759603
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Lymphocytic Leukemia Small Lymphocytic Lymphoma

Start date: 2008-09-01
Primary completion: 2014-07-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.